Viewing Study NCT03300934


Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2026-01-08 @ 6:58 PM
Study NCT ID: NCT03300934
Status: COMPLETED
Last Update Posted: 2018-07-31
First Post: 2017-09-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adolescence and Diabetes:Can an Automated Closed Loop System Improve Control ?
Sponsor: Centre Hospitalier du Luxembourg
Organization:

Study Overview

Official Title: Adolescence and Diabetes: Can an Automated Closed Loop System Improve Control ?
Status: COMPLETED
Status Verified Date: 2018-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SPIDIMAN2
Brief Summary: This study evaluates the use of the FD2 automated closed loop insulin administration in Adolescents with a poor metabolic control . All youth will be treated in a random order by their usual pump treatment or an Automated system and we will evaluate whether this has an impact on metabolic control and sleep
Detailed Description: Achievement of a good metabolic control is very important for all persons with diabetes . In adolescence many changes occur , physically , socially and psychologically .This may influence the metabolic control . This study will evaluate whether the automated closed-loop will facilitate and improve the management of diabetes in youth with a poor metabolic control.

It is a single-centre, randomised, two-period crossover study to assess the efficacy /safety and acceptability of the automated closed-loop glucose control (CL) day and night, over 28 days in comparison with continuous subcutaneous insulin infusion (CSII) in the home setting in poorly controlled type 1 diabetes adolescents.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: